Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Case report

Cytarabine

Cardiogenic shock secondary to Takotsubo cardiomyopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Baumann S, et al. Takotsubo cardiomyopathy after systemic consolidation therapy with high-dose intravenous cytarabine in a patient with acute myeloid Leukemia. Oncology Research and Treatment 37: 487-490, No. 9, Aug 2014. Available from: URL: http://doi.org/10.1159/000365536 - GermanyCrossRefPubMed Baumann S, et al. Takotsubo cardiomyopathy after systemic consolidation therapy with high-dose intravenous cytarabine in a patient with acute myeloid Leukemia. Oncology Research and Treatment 37: 487-490, No. 9, Aug 2014. Available from: URL: http://​doi.​org/​10.​1159/​000365536 - GermanyCrossRefPubMed
Metadaten
Titel
Cytarabine
Cardiogenic shock secondary to Takotsubo cardiomyopathy: case report
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-1875-0

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Dexmedetomidine

Case report

Pramipexole

Case report

Prednisolone

Case report

Doxycycline